Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer

[Image: see text] Introduction: Early-activated RAS/RAF mutation status is a key molecular finding in colorectal cancer (CRC), while these mutations have been proposed as predictive and prognostic biomarkers. The present study has been designed as a longitudinal study to evaluate and summarize the d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bioimpacts
Main Authors: Dolatkhah, Roya, Dastgiri, Saeed, Eftekhar Sadat, Amir Taher, Farassati, Faris, Nezamdoust, Marzieh, Somi, Mohammad Hossein
Formato: Artigo
Idioma:Inglês
Publicado em: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803924/
https://ncbi.nlm.nih.gov/pubmed/33469503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34172/bi.2021.02
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados